NEW YORK / Apr 19, 2023 / Business Wire / As more Americans continue to seek information about mental health conditions based online, Talkspace, the leading provider of virtual behavioral health services, today announced the launch of its new “Mental Health Conditions Library.” The new site will be available to (both members and non-members of the Talkspace service) with free, clinically-evaluated, human-authored articles and information on a comprehensive range of mental health conditions. The library will also provide information on available treatments related to those conditions.
“TikTok and other social media channels have raised awareness, and helped destigmatize mental health conditions like anxiety, depression and ADHD, but it comes with a risk,” said Dr. Varun Choudhary, Chief Medical Officer of Talkspace. “It can lead to people self-diagnosing or hastily seeking inappropriate treatments, so we brought together a team of licensed Talkspace clinicians to add a layer of professional insight, nuance, and approachability with this educational resource. We are meeting people where they are in this age of self-help-meets-social-media.”
More than 30 conditions appear alphabetically, and each one is described in an approachable, easy to understand manner defined in accordance with the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM 5). The corresponding entries also describe each condition’s symptoms, examples of appropriate coping mechanisms and treatments, ranging from self-care to therapy to medication for more severe cases, and links to an assessment. The assessment will help guide individuals in evaluating if they should seek help from a licensed mental health professional to address their concerns.
All content in the Mental Health Conditions Library is authored by specialized writers and reviewed by a dedicated team of licensed, practicing Talkspace mental health clinicians. The Clinical Review Process includes: 1) the fact-checking of all mental health claims and statements, backed by current research from credible sources, including peer-reviewed journals and educational institutions, 2) ensuring content is accessible to a diverse range of individuals and addresses their unique mental health needs, and finally, the Library Includes guidance on how the reader might move forward if they believe they are experiencing the conditions, including the option to access virtual care through Talkspace.
Visit Talkspace’s new Mental Health Conditions Library here.
About Talkspace
Talkspace (NASDAQ: TALK) is a leading virtual behavioral healthcare company committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall health and should be available to everyone.
Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual and couples therapy, in addition to psychiatric treatment and medication management. With Talkspace’s core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including live video, text or audio chat sessions and/or unlimited, asynchronous text messaging.
All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Talkspace covered approximately 92 million lives at December 31, 2022, through partnerships with insurance and employee assistance programs or other network behavioral health paid benefit programs.
For more information, visit https://www.talkspace.com/
Last Trade: | US$3.04 |
Daily Change: | -0.13 -4.10 |
Daily Volume: | 2,048,192 |
Market Cap: | US$511.360M |
October 29, 2024 September 04, 2024 August 06, 2024 July 24, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB